Skip to content

Lobbying by Maternal Infant Child and Youth Research Network (MICYRN): its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Organization

Maternal Infant Child and Youth Research Network (MICYRN)

Meetings this Parliament
2
With MPs
0
Since Nov 2021
2
Active registrations
1

Most recent reported meeting: Jun 3, 2026.

Bills they've lobbied on

Named in their own descriptions of meetings or of their registration. Their words are quoted below each bill.

Who they meet

Since the current Parliament opened.

Institutions

  • Health Canada (HC)2

Registrations in effect

In-house (organization) In effect since May 20, 2026 Receives government funding

Filed by Breanne Stewart, Director

Lobbyists

  • Barbara Storey · Director of Operations
  • Breanne Stewart · Director

Institutions they may lobby: Canadian Institutes of Health Research (CIHR), Health Canada (HC), Innovation, Science and Economic Development Canada (ISED)

What they're lobbying on (2)
  • Regulatory pathways for therapies that are not commercially viable for pediatric rare diseases.
  • Working with federal partners to streamline Health Canada policies and processes related to clinical trials and drug authorization specific to children, specifically Bill C 265: An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access).

Registration 964513-385927-2. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Breanne Stewart · In-house (organization)

    • Ming Su · Director, Centre for Policy, Pediatrics and International Collaboration, Health Canada (HC)
    Regulatory pathways for therapies that are not commercially viable for pediatric rare diseases.

    Official report

  • Reported by Breanne Stewart · In-house (organization)

    • David Lee · Chief Regulatory Officer, Health Canada (HC)
    Regulatory pathways for therapies that are not commercially viable for pediatric rare diseases.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.